Coming in 2018

20/20 introduces OneTEST, a new multi cancer test which can help detect over 6 types of cancer, with up to 90% accuracy, using a standard blood test.

OneTEST will be available in the US beginning Q2 2018.

Using 20/20 Hindsight:

Our innovative business model uses advanced analytics on large volumes of real world, clinically relevant patient health data collected from hospital centers where tumor biomarker testing has been used for many years.

Making Things Happen

We believe much of the innovation in cancer diagnostics for the coming decade will come from applying powerful data analytics to proven cancer biomarkers.

Artificial Intelligence

20/20 is using the power of realworld data and powerful A.I. driven algorithms to drive development of new tests for early detection of cancers that are affordable and accessible to hospitals all over the world.

PAULA’s Test:

20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. 

Biocheck Logo

BioCheck® Suspicious Powder Test Kit

Screen for multiple bioterror agents and rule out most false alarms.